SCHEMBL7429885

SCHEMBL7429885

Cc1ccc2[nH]c(=O)cc(C(=O)O)c2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.66
ALDH1A1 P00352 6/20 0.66
POLB P06746 3/20 0.66
GAA P10253 2/20 0.66
TDP1 Q9NUW8 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
MAPT P10636 3/20 0.65
PKM P14618 1/20 0.65
KMT2A Q03164 6/20 0.59
MEN1 O00255 5/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
HSD17B10 Q99714 3/20 0.50
HTT P42858 2/20 0.50
HPGD P15428 2/20 0.50
GFER P55789 1/20 0.50
NPC1 O15118 2/20 0.46
PIN1 Q13526 1/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
LMNA P02545 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16938811 0.83 KDM4E (0.72) KDM4EALDH1A1POLBGAATDP1
SCHEMBL28982768 0.81 KDM4E (0.63) KDM4EALDH1A1POLBGAATDP1
SCHEMBL24840849 0.80 KDM4E (0.61) KDM4EALDH1A1POLBGAATDP1
SCHEMBL8363345 0.80 KDM4E (0.61) KDM4EALDH1A1POLBGAATDP1
SCHEMBL4995111 0.80 KDM4E (0.61) KDM4EALDH1A1POLBGAATDP1
SCHEMBL28982738 0.80 KDM4E (1.00) KDM4EALDH1A1POLBGAATDP1
SCHEMBL2054593 0.80 KDM4E (0.61) KDM4EALDH1A1POLBGAATDP1
SCHEMBL2056336 0.80 KDM4E (0.61) KDM4EALDH1A1POLBGAATDP1
SCHEMBL31475465 0.78 LMNA (0.67) KDM4EALDH1A1POLBGAAMAPT
SCHEMBL9724162 0.78 LMNA (0.67) KDM4EALDH1A1POLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745960-B Compound containing quinolinone amide, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-08-30 CN disclosed
WO-2023030459-A1 QUINOLINONE AMIDE-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 中国科学院上海药物研究所 2023-03-09 WO disclosed
CN-115745960-A Quinolinone amide-containing compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2023-03-07 CN disclosed
EP-2102189-B1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-07-29 EP disclosed
US-8466295-B2 Thiophene derivatives as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-06-18 US disclosed
US-8410155-B2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-02 US disclosed
EP-1981854-B1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-06-01 EP disclosed
WO-2008076805-A2 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-06-26 WO disclosed
WO-2007070818-A1 SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed
EP-0458636-B1 Antiemetic and migraine suppressing heterocyclic compounds and pharmaceutical compositions containing them KYOWA HAKKO KOGYO KK (JP) 1995-07-12 EP disclosed
US-5248684-A CERTAIN 2-OXO-QUINOLINE CARBOXYLATES OR CORRESPONDING CARBOXAMIDES USEFUL AS ANTI-EMETICS AND SUPPRESSANTS OF MIGRAINE KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-09-28 US disclosed
EP-0458636-A1 Antiemetic and migraine suppressing heterocyclic compounds and pharmaceutical compositions containing them KYOWA HAKKO KOGYO CO., LTD (JP) 1991-11-27 EP disclosed